Overview

Low Dose Cyclosporin A in Primary Sjögren Syndrome

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Sandimmun optoral (Cyclosporin A) is used for the musculoskeletal manifestations of Primary Sjögren Syndrome
Phase:
Phase 2
Details
Lead Sponsor:
Charite University, Berlin, Germany
Treatments:
Cyclosporine
Cyclosporins